Category: carcinoid

Edward Wolin, MD_3

March Luncheon with the Experts in New York City

January 31, 2019

Join neuroendocrine tumor (NET) patients in New York City on Sunday, March 10, 2019 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…

READ MORE
Edward Wolin, Matthew Kulke, Pamela Kunz, Yi-Zarn Wang

News about Neuroendocrine Cancer Expert Physicians

January 8, 2018

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has been named Director

READ MORE
Carcinoid Syndrome Focus Groups wordcloud

Seeking Participants for Carcinoid Syndrome and Carcinoid Tumor Focus Groups in July

June 19, 2017

Schlesinger Associates, a leading medical marketing research specialist, is seeking patients diagnosed with Carcinoid Syndrome and Carcinoid Tumors to participate in small focus group interviews on the topic of Carcinoid Syndrome and associated

READ MORE
App, international release April 2017

Carcinoid NETs Health Storylines — Now Available in Seven Countries

April 17, 2017
 Are you from the UK, Ireland, Australia, New Zealand, or Singapore? A new self-care management tool for Carcinoid and Neuroendocrine Tumors (NETs) is now available for you!

The Carcinoid Cancer Foundation (CCF) and our partner Self Care Catalysts (SCC)

READ MORE
Luncheon with the Experts, May 21, 2017, Drs. Ratner, Warner, Zacks (l to r)

May Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community

April 9, 2017

Join carcinoid and neuroendocrine tumor patients in New York City on Sunday, May 21, 2017 for a unique opportunity to have lunch with three medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues…

READ MORE
2015-highlights

Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)

April 6, 2017

The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.

PLEASE SCROLL DOWN FOR A STATE-BY STATE LISTREAD MORE
carcinoid-syndrome-presentation-of-symptoms-diagram-wikipedia_2

Carcinoid Syndrome Impact Survey Results to Be Presented During September 21 Webcast

September 14, 2016

Members of the carcinoid and neuroendocrine tumor community are invited to be the first to hear the results of the Carcinoid Syndrome Impact Survey that was conducted this summer.  A Webcast about the survey results will be presented on Wednesday, September

READ MORE
project_zebra_4

Show Your Stripes by Contributing to Carcinoid and NET Research

August 17, 2016

 

Dear Friends,

Don’t miss this opportunity to Show Your Stripes by participating in the first ever Project Zebra: Real-World Patient Journey Research for Carcinoid and Neuroendocrine Tumors in the United States.

The Carcinoid Cancer Foundation…

READ MORE
Los-Angeles-Conference-June-2016Flyer_2

Los Angeles Neuroendocrine Tumor Patient Education Conference 2016

June 14, 2016

Join neuroendocrine tumor (NET) patients and family members, NET cancer expert physicians, and members of the healthcare community on Saturday, June 25, 2016 for a free, one-day conference at Cedars-Sinai Medical Center in Los Angeles.  The conference…

READ MORE
aboutcarcinoid_3

New Survey for the Carcinoid Syndrome Community

June 7, 2016

Dear Friends,

We are excited to invite you to participate in the new Carcinoid Syndrome Impact Survey, which is designed to help better understand the impact that carcinoid syndrome has on patients’ lives, while also exploring physicians’ treatment…

READ MORE